{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 409,
  "pageCount": 415,
  "prevPage": 408,
  "nextPage": 410,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes to build a narrative of expert doubt.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/409",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-409",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I keep on getting back to the thing that concerns me the most is that I was not as aware. I had my concerns, but you're giving me a lot more concern that the people who are most in the know and most involved seem to be very, very uncomfortable with it. And that is giving me pause as well.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64cf-7128-a313-479a23e823f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.73
      },
      "kind": "list",
      "text": "Concerned about small trial size; wants to review the data again after our questions; “beginning to wonder”\n“A lot of it is going to be, it's going to be real world because the trial itself is small. You're basically making me go back and look at all the data again, because now I'm much more concerned about some of the things that you bring up. I was hoping that it would have utility in maybe 3 or 4 of my patients if I could get it approved. Now I'm beginning to wonder whether maybe I need to have a different type of focus in terms of what I want to do right now so that .” – Endocrinologist based in NYC, 15 PWS patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33ec335c-4bd4-49b9-a34d-b978227e58ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.57
      },
      "kind": "list",
      "text": "Had pre-existing concerns about Vykat; also concerned at skepticism by trial investigators\n“I keep on getting back to the thing that concerns me the most is that I was not as aware. I had my concerns, but you're giving me a lot more concern that the people who are most in the know and most involved seem to be very, very uncomfortable with it. And that is giving me pause as well.” – Endocrinologist based in NYC, 15 PWS patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c0f6b9a-04b4-46ab-9fc8-507ed7b5e523",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.41
      },
      "kind": "list",
      "text": "“Suspicious”\nQ: “I spoke with a key trial investigator and he said he didn't see $500,000 worth of benefit from the drug, not even $5,000 worth of benefit of the drug. And I asked him how many of his 50 patients he has on Vykat. He said none.”\nA: “I tend to be a little bit suspicious as well.” - Endocrinologist based in NYC, 15 PWS patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c42fb663-085a-4116-99de-c69de6114731",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "The endocrinologist stated he was particularly concerned after we shared color from study investigators with a negative opinion of Vykat, and that it reinforced his pre-existing skepticism: “I tend to be a little bit suspicious as well”; “the thing that concerns me the most is that I was not as aware...I had my concerns, but you're giving me a lot more concern that the people who are most in the know and most involved seem to be very, very uncomfortable with it”; “the trial itself is small...you're basically making me go back and look at all the data again, because now I'm much more concerned about some of the things that you bring up....”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "306d5746-d0d2-491b-9136-085014cfaf15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"I tend to be a little bit suspicious as well.\" — Endocrinologist based in NYC, 15 PWS patients; \"I keep on getting back to the thing that concerns me the most is that I was not as aware. I had my concerns, but you're giving me a lot more concern that the people who are most in the know and most involved seem to be very, very uncomfortable with it. And that is giving me pause as well.\" — Endocrinologist based in NYC, 15 PWS patients; \"A lot of it is going to be, it's going to be real world because the trial itself is small. You're basically making me go back and look at all the data again, because now I'm much more concerned about some of the things that you bring up. I was hoping that it would have utility in maybe 3 or 4 of my patients if I could get it approved. Now I'm beginning to wonder whether maybe I need to have a different type of focus in terms of what I want to do right now so that .\" — Endocrinologist based in NYC, 15 PWS patients",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64cf-7128-a313-49abb1eed5fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fc04cff-d8dd-41a5-bc77-8b1093ee8cd3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}